All about the company ​Freeline - Maddyness

The Company Profile
hide
the pitch

Freeline is a privately-held clinical-stage biotechnology company focused on AAV based gene therapy targeting the liver. Our vision is to create better lives for people suffering from chronic systemic diseases using the potential of gene therapy as a one-off curative treatment. Freeline has developed a next-generation AAV based gene therapy platform to provide treatments for a wide range of diseases like haemophilia B, Fabry and Gaucher Disease which have previously been underserved and incurable. We are headquartered in the UK and we also have operations in Germany and the US.

the head office

Stevenage

created in

2015

Lastest funding
Freeline
#biotech
Novo Holdings, Eventide Asset Management, Wellington Management Company, Cowen Healthcare Investments, Acorn Bioventures, Ample Plus Fund
£95.8M
Series C
Corresponding articles
Corresponding articles
Business
Menu
Entrepreneurs
Menu
Finance
Menu
Innovation
Menu
Technology
Menu
Agenda
Calendar
MaddyEvent
MaddyEvent
MaddyStudio
MaddyStudio
Search
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Most viewed articles
Newsletter
About
Legal Information
Search
Our services
Categories
Maddynews
Hmm ... There's a problem :(
Maddyness

Comme vous le savez, Maddyness est à la pointe de l'innovation.
Malheureusement il semble que votre navigateur ne le soit pas encore...

Pour une bonne expérience de navigation
(et être au top de la modernité) pensez à passer sur :
Chrome
Chrome
Safari
Safari
Firefox
Firefox
Edge
Edge